H. Direskeneli Et Al. , "Thalidomide has both anti-inflammatory and regulatory effects in Behcet's disease," CLINICAL RHEUMATOLOGY , vol.27, no.3, pp.373-375, 2008
Direskeneli, H. Et Al. 2008. Thalidomide has both anti-inflammatory and regulatory effects in Behcet's disease. CLINICAL RHEUMATOLOGY , vol.27, no.3 , 373-375.
Direskeneli, H., Ergun, T., Yavuz, S., Hamuryudan, V., & Eksioglu-Demiralp, E., (2008). Thalidomide has both anti-inflammatory and regulatory effects in Behcet's disease. CLINICAL RHEUMATOLOGY , vol.27, no.3, 373-375.
Direskeneli, H. Et Al. "Thalidomide has both anti-inflammatory and regulatory effects in Behcet's disease," CLINICAL RHEUMATOLOGY , vol.27, no.3, 373-375, 2008
Direskeneli, H. Et Al. "Thalidomide has both anti-inflammatory and regulatory effects in Behcet's disease." CLINICAL RHEUMATOLOGY , vol.27, no.3, pp.373-375, 2008
Direskeneli, H. Et Al. (2008) . "Thalidomide has both anti-inflammatory and regulatory effects in Behcet's disease." CLINICAL RHEUMATOLOGY , vol.27, no.3, pp.373-375.
@article{article, author={H. Direskeneli Et Al. }, title={Thalidomide has both anti-inflammatory and regulatory effects in Behcet's disease}, journal={CLINICAL RHEUMATOLOGY}, year=2008, pages={373-375} }